Press Release
Consult the important information that Servier Canada wishes to share with the press in the form of press releases.
2024, October 22
Health Canada Approves First and Only Oral Targeted Treatment for Brain Cancer
2023, June 5
FDA and EMA Accept Vorasidenib Regulatory Submissions for Marketing Approval of Vorasidenib for the Treatment of IDH-mutant Diffuse Glioma
2024, February 20